Related Experiment Videos
Purification of an ascomycin derivative with simulated moving bed chromatography. A case study
E Küsters1, C Heuer, D Wieckhusen
1Chemical and Analytical Development, Novartis Pharma AG, Basel, Switzerland. ernst.kuesters@pharma.novartis.com
Abstract:
A purification process was developed for the separation of a semi-synthetic ascomycin derivative from its by-products. The process consists of a silica gel filtration and crystallization step prior to two simulated moving bed (SMB) separations, where in the first part the polar by-products and in the second part the apolar by-products were removed. The desired purity was achieved in a final crystallization step. Key elements of the whole process were the design of the first crystallization to obtain a product feasible for SMB chromatography and the specification of operating parameters for the two corresponding SMB steps. Starting from a crude product with an assay of only 44.9% an overall yield for the whole process of 81.0% was achieved with a final purity of >98%.